Transcriptional activation of endoglin and transforming growth factor-β signaling components by cooperative interaction between Sp1 and KLF6: Their potential role in the response to vascular injury

Blood

Volumn 100, Issue 12, 2002, Pages 4001-4010

  Botella, Luisa M ^a,b,c,d,e   Sánchez Elsner, Tilman ^a,b,c,d,e   Sanz Rodriguez, Francisco ^a,b,c,d,e   Kojima, Soichi ^a,b,c,d,e   Shimada, Jun ^a,b,c,d,e   Guerrero Esteo, Mercedes ^a,b,c,d,e   Cooreman, Michael P ^a,b,c,d,e   Ratziu, Vlad ^a,b,c,d,e   Langa, Carmen ^a,b,c,d,e   Vary, Calvin P H ^a,b,c,d,e   Ramírez, Jose R ^a,b,c,d,e   Friedman, Scott ^a,b,c,d,e   Bernabéu, Carmelo ^a,b,c,d,e  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b RIKEN   (Japan)

^c HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e Maine Medical Center Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; ENDOGLIN; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR KLF6; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; BALLOON; CAROTID ARTERY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; VASCULAR ENDOTHELIUM;

EID: 0036893431     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.12.4001     Document Type: Article

References (61)

1. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med. 1994;331: 1286-1292.
2. Martin P. Wound healing-aiming for perfect skin regeneration. Science. 1997;276:75-81.
3. Olaso E, Friedman SL. Molecular regulation of hepatic fibrogenesis. J Hepatol. 1998;29:836-847.
4. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60-66.
5. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med. 1999;340:115-126.
6. Reidy MA, Irvin C, Lindner V. Migration of arterial wall cells: Expression of plasminogen activators and inhibitors in injured rat arteries. Circ Res. 1996;78:405-414.
7. Carmeliet P, Moons L, Lijnen R, et al. Urokinase generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet. 1997;17:439-444.
8. Wysocki SJ, Zheng MH, Fan Y, Lamawansa MD, House AK, Norman PE. Expression of transforming growth factor β- and urokinase-type plasminogen activator genes during arterial repair in the pig. Cardiovasc Res. 1996;31:28-36.
9. Shi Y, O'Brien JE, Fard A, Zalewski A. Transforming growth factor-beta 1 expression and myofibroblast formation during arterial repair. Arterioscler Thromb Vasc Biol. 1996;16:1298-1305.
10. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors. 1993;8:1-9.
11. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J Clin Invest. 1994;93:1172-1178.
12. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol. 2000;1:169-178.
13. Attisano L, Wrana JL. Smads as transcriptional co-modulators. Curr Opin Cell Biol. 2000;12:235-243.
14. Cheifetz S, Bellón T, Calés C, et al. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem. 1992;267:19027-19030.
15. Lastres P, Letamendia A, Zhang H, et al. Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol. 1996;133:1109-1121.
16. Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem. 1999;274:584-594.
17. Gougos A, Letarte M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol. 1988;141:1925-1933.
18. Li C, Guo B, Bernabeu C, Kumar S. Angiogenesis in breast cancer: The role of transforming growth factor beta and CD105. Microsc Res Tech. 2000; 52:437-449.
19. Lastres P, Bellon T, Cabanas C, et al. Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. Eur J Immunol. 1992;22:393-397.
20. St-Jacques S, Cymerman U, Pece N, Letarte M. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells. Endocrinology. 1994;134:2645-2657.
21. Adam PJ, Clesham GJ, Weissberg PL. Expression of endoglin mRNA and protein in human vascular smooth muscle cells. Biochem Biophys Res Comm. 1998;247:33-37.
22. Conley BA, Smith JD, Guerrero-Esteo M, Bernabeu C, Vary CP. Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques. Atherosclerosis. 2000;153:323-335.
23. Ou R, Silver MM, Letarte M. Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation. Cell Tissue Res. 1998;292:333-343.
24. Vincent EB, Runyan RB, Weeks DL. Production of the transforming growth factor-beta binding protein endoglin is regulated during chick heart development. Dev Dyn. 1998;213:237-247.
25. Li DY, Sorensen LK, Brooke BS, et al. Defective angiogenesis in mice lacking endoglin. Science. 1999;284:1534-1537.
26. Bourdeau A, Dumont DJ, Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest. 1999;104:1343-1351.
27. Arthur HM, Ure J, Smith AJ, et al. Endoglin, an ancillary TGF-β receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol. 2000;217:42-53.
28. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, A TGF-β binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type I. Nat Genet. 1994;8:345-351.
29. Guttmacher AE, Marchuk DA, White RI. Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995;333:918-924.
30. Shovlin C, Letarte M. Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: Issues in clinical management and review of pathogenic mechanisms. Thorax. 1999; 54:714-729.
31. Bernard G, Mion F, Henry L, Plauchu H, Paliard P. Hepatic involvement in hereditary hemorrhagic telangiectasia: Clinical, radiological, and hemodynamic studies of 11 cases. Gastroenterology. 1993;105:482-487.
32. Pece-Barbara N, Cymerman U, Vera S, Marchuk DA, Letarte M. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. Hum Mol Genet. 1999;8:2171-2181.
33. Rius C, Smith JD, Almendro N, et al. Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1. Blood. 1998;92:4677-4690.
34. Botella LM, Sanchez-Elsner T, Rius C, Corbi A, Bernabeu C. Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-β stimulation. J Biol Chem. 2001;276:34486-34494.
35. Ma X, Labinaz M, Goldstein J, et al. Endoglin is overexpressed after arterial injury and is required for transforming growth factor-β induced inhibition of smooth muscle cell migration. Arterioscler Thromb Vasc Biol. 2000;20:2546-2552.
36. Lalazar A, Wong L, Yamasaki G, Friedman SL. Early genes induced in hepatic stellate cells during wound healing. Gene. 1997;195:235-243.
37. Ratziu V, Lalazar A, Wong L, et al. Zf9, a Krüppel like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci U S A. 1998;95:9500-9505.
38. Suzuki T, Yamamoto T, Kurabayashi M, Nagai R, Yazaki Y, Horikoshi M. Isolation and initial characterization of GBF a novel DNA binding zinc finger protein that binds to the GC-rich binding sites of the HIV-1 promoter. J Biochem (Tokyo). 1998; 124:389-395.
39. Kojima S, Hayashi S, Shimokado K, et al. Transcriptional activation of urokinase by the Krüppellike factor Zf9/COPEB activates latent TGF-β in vascular endothelial cells. Blood. 2000;95:1309-1316.
40. Kim Y, Ratziu V, Choi SG, et al. Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1: Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem. 1998;273:33750-33758.
41. Pichuantes S, Vera S, Bourdeau A, et al. Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments. Tissue Antigens. 1997; 50:265-276.
42. Nordeen SK. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques. 1988;6:454-458.
43. Gill G, Pascal E, Tseng ZH, Tjian R. A glutaminerich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc Natl Acad Sci U S A. 1994; 91:192-196.
44. Rippe RA, Almounajed G, Brenner DA. Sp1 binding activity increases in activated Ito cells. Hepatology. 1995;22:241-251.
45. Suzuki Y, Shimada J, Shudo K, Matsumura M, Crippa MP, Kojima S. Physical interaction between retinoic acid receptor and Sp1: Mechanism for induction of urokinase by retinoic acid. Blood. 1999;93:4264-4276.
46. Paquet ME, Pece-Barbara N, Vera S, et al. Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function. Hum Mol Genet. 2001;10:1347-1357.
47. Bellon T, Corbi A, Lastres P, et al. Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol. 1993;9:2340-2345.
48. Letarte M, Bourdeau A, Vera S, et al. CD105 Workshop panel report. In: Kishimoto T, Kikutani H, von dem Borne AEGK, et al, eds. Leucocyte Typing VI. New York, NY: Garland Publishing; 1997:703-708.
49. Graulich W, Nettelbeck DM, Fischer D, Kissel T, Muller R. Cell type specificity of the human endoglin promoter. Gene. 1999;227:55-62.
50. Dang DT, Pevsner J, Yang VW. The biology of the mammalian Kruppel-like family of transcription factors. Int J Biochem Cell Biol. 2000;32:1103- 1121.
51. Kambe T, Tada-Kambe J, Kuge Y, Yamaguchi-Iwai Y, Nagao M, Sasaki R. Retinoic acid stimulates erythropoietin gene transcription in embryonal carcinoma cells through the direct repeat of a steroid/thyroid hormone receptor response element half-site in the hypoxia-response enhancer. Blood. 2000;96:3265-3271.
52. Crossley M, Merika M, Orkin SH. Self-association of the erythroid transcription factor GATA-1 mediated by its zinc finger domains. Mol Cell Biol. 1995;15:2448-2456.
53. Mackay JP, Crossley M. Zinc fingers are sticking together. Trends Biochem Sci. 1998;23:1-4.
54. Philipsen S, Suske G. A tale of three fingers: The family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 1999;27:2991-3000.
55. Clemens KR, Wolf V, McBryant SJ, et al. Molecular basis for specific recognition of both RNA and DNA by a zinc finger protein. Science. 1993;260: 530-533.
56. Gregory RC, Taxman DJ, Seshasayee D, Kensinger MH, Bieker JJ, Wojchowski DM. Functional interaction of GATA1 with erythroid Kruppel-like factor and Sp1 at defined erythroid promoters. Blood. 1996;87:1793-1801.
57. Pugh BF, Tjian R. Mechanism of transcriptional activation by Sp1: Evidence for coactivators. Cell. 1990;61:1187-1197.
58. el-Baradi T, Pieler T. Zinc finger proteins: What we know and what we would like to know. Mech Dev. 1991;35:155-169.
59. Khachigian LM, Lindner V, Williams AJ, Collins T. Egr-1-induced endothelial gene expression: A common theme in vascular injury. Science. 1996;271:1427-1431.
60. Zhao JL, Austen KF, Lam BK. Cell-specific transcription of leukotriene C4 synthase involves a Kruppel-like transcription factor and Sp1. J Biol Chem. 2000;275:8903-8910.
61. Torsney E, Charlton R, Parums DV, Collis M, Arthur HM. Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res. 2002;51:464-470.